Trial Profile
The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Mar 2016
Price :
$35
*
At a glance
- Drugs Tegaserod (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Novartis
- 10 Mar 2016 New trial record